,title,source,link,date
56,Ivonescimab Challenges Tislelizumab Plus Chemo in Advanced ...,Targeted Oncology,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2l2b25lc2NpbWFiLWNoYWxsZW5nZXMtdGlzbGVsaXp1bWFiLXBsdXMtY2hlbW8taW4tYWR2YW5jZWQtZWdmci1ucy1uc2NsY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
9,Up-to-date meta-analysis of long-term evaluations of mesenchymal ...,Newswise,news.google.com/articles/CBMikQFodHRwczovL3d3dy5uZXdzd2lzZS5jb20vYXJ0aWNsZXMvdXAtdG8tZGF0ZS1tZXRhLWFuYWx5c2lzLW9mLWxvbmctdGVybS1ldmFsdWF0aW9ucy1vZi1tZXNlbmNoeW1hbC1zdGVtLWNlbGwtdGhlcmFweS1mb3ItY29tcGxleC1wZXJpYW5hbC1maXN0dWxh0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
30,Next Steps for Acalabrutinib in MCL,Targeted Oncology,news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L25leHQtc3RlcHMtZm9yLWFjYWxhYnJ1dGluaWItaW4tbWNs0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
21,Participants Debate Which Combination Is Best for High-Risk ...,Targeted Oncology,news.google.com/articles/CBMibWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L3BhcnRpY2lwYW50cy1kZWJhdGUtd2hpY2gtY29tYmluYXRpb24taXMtYmVzdC1mb3ItaGlnaC1yaXNrLW11bHRpcGxlLW15ZWxvbWHSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
79,Genomic Analyses Reveals Complex Alterations in HGSC,AJMC.com Managed Markets Network,news.google.com/articles/CBMiTmh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvZ2Vub21pYy1hbmFseXNlcy1yZXZlYWxzLWNvbXBsZXgtYWx0ZXJhdGlvbnMtaW4taGdzY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
74,Combining Surgery and Biologic Therapy Improves Outcomes in ...,AJMC.com Managed Markets Network,news.google.com/articles/CBMiamh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvY29tYmluaW5nLXN1cmdlcnktYW5kLWJpb2xvZ2ljLXRoZXJhcHktaW1wcm92ZXMtb3V0Y29tZXMtaW4tcGF0aWVudHMtd2l0aC1jcnN3bnDSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
71,Patients With ILD Identify Oxygen Therapy Barriers,AJMC.com Managed Markets Network,news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvcGF0aWVudHMtd2l0aC1pbGQtaWRlbnRpZnktb3h5Z2VuLXRoZXJhcHktYmFycmllcnPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
69,"Study Suggests CAR T-Cell Therapy Safe, Effective After Allo-SCT in ...",AJMC.com Managed Markets Network,news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvc3R1ZHktc3VnZ2VzdHMtY2FyLXQtY2VsbC10aGVyYXB5LXNhZmUtZWZmZWN0aXZlLWFmdGVyLWFsbG8tc2N0LWluLW11bHRpcGxlLW15ZWxvbWHSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
68,Ceribell's Status Epilepticus Software Receives FDA Clearance With ...,AJMC.com Managed Markets Network,news.google.com/articles/CBMid2h0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvY2VyaWJlbGwtcy1zdGF0dXMtZXBpbGVwdGljdXMtc29mdHdhcmUtcmVjZWl2ZXMtZmRhLWNsZWFyYW5jZS13aXRoLWNtcy1udGFwLWNvdmVyYWdlLWluY2x1ZGVk0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
37,Charina Toste Discusses the Educational Obstacles Patients With ...,www.oncnursingnews.com/,news.google.com/articles/CBMibWh0dHBzOi8vd3d3Lm9uY251cnNpbmduZXdzLmNvbS92aWV3L2NoYXJpbmEtdG9zdGUtZGlzY3Vzc2VzLXRoZS1lZHVjYXRpb25hbC1vYnN0YWNsZXMtcGF0aWVudHMtd2l0aC1tcG5zLWZhY2XSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
